Invention Grant
- Patent Title: Fused furans for the treatment of hepatitis C
-
Application No.: US14773123Application Date: 2014-03-12
-
Publication No.: US09738653B2Publication Date: 2017-08-22
- Inventor: Kap-Sun Yeung , Kyle J. Eastman , Kyle E. Parcella
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent James Epperson
- International Application: PCT/US2014/024181 WO 20140312
- International Announcement: WO2014/159559 WO 20141002
- Main IPC: C07D491/048
- IPC: C07D491/048 ; C07D491/04 ; C07D307/84
Abstract:
The disclosure provides compounds of formula I or II, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
Public/Granted literature
- US20160024103A1 FUSED FURANS FOR THE TREATMENT OF HEPATITIS C Public/Granted day:2016-01-28
Information query
